Javascript must be enabled to continue!
Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
View through CrossRef
Background: Post phototherapy rebound hyperbilirubinemia is a cause for readmission in some infants.However, this phenomenon data of rebound hyperbilirubinemia is lacking from Indonesia. Our study aimsto describe the risk factor of post phototherapy rebound hyperbilirubinemia in the infant.Method: Cross-sectional study of all infants with indirect hyperbilirubinemia who were treated phototherapyaccording to standard guidelines in neonate intermediate unit Dr. Soetomo hospital for 6 months from June2017 until December 2017. Bilirubin was measured 24 hours after phototherapy. Bilirubin rebound isconsidered as increasing total serum bilirubin that needs reinstitution of phototherapy.Result: A total of 53 (44.9%) infants developed rebound hyperbilirubinemia. We revealed the following riskfactor for rebound hyperbilirubinemia was the onset of jaundice on < 3 days, (10 babies, p <0.05). Otherresults are 30 (56.6%) female infants, 39 (73%) birth weight < 2500 g, 36 (67%) infants with a history ofcesarean section, and 38 (71%) preterm infants but there are not statistically significant.Conclusion: Post phototherapy rebound hyperbilirubinemia should be considered in the onset of jaundice< 3 days.
Institute of Medico-legal Publications Private Limited
Title: Risk Factors of Rebound Hyperbilirubinemia in Post Phototherapy Hyperbilirubinemia Infants
Description:
Background: Post phototherapy rebound hyperbilirubinemia is a cause for readmission in some infants.
However, this phenomenon data of rebound hyperbilirubinemia is lacking from Indonesia.
Our study aimsto describe the risk factor of post phototherapy rebound hyperbilirubinemia in the infant.
Method: Cross-sectional study of all infants with indirect hyperbilirubinemia who were treated phototherapyaccording to standard guidelines in neonate intermediate unit Dr.
Soetomo hospital for 6 months from June2017 until December 2017.
Bilirubin was measured 24 hours after phototherapy.
Bilirubin rebound isconsidered as increasing total serum bilirubin that needs reinstitution of phototherapy.
Result: A total of 53 (44.
9%) infants developed rebound hyperbilirubinemia.
We revealed the following riskfactor for rebound hyperbilirubinemia was the onset of jaundice on < 3 days, (10 babies, p <0.
05).
Otherresults are 30 (56.
6%) female infants, 39 (73%) birth weight < 2500 g, 36 (67%) infants with a history ofcesarean section, and 38 (71%) preterm infants but there are not statistically significant.
Conclusion: Post phototherapy rebound hyperbilirubinemia should be considered in the onset of jaundice< 3 days.
Related Results
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
Background: Thrombocytopenia as a side effect of phototherapy has not been mentioned in standard literature and textbooks. Though there are few studies in this regard, but results ...
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
19 Treatment of Neonatal Hyperbilirubinemia – Ontario Cohort 2014-2018
Abstract
Background
Serious complications that could result from severe neonatal hyperbilirubinemia include acute and chronic bi...
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Double versus Single Phototherapy in the Treatment of Neonatal Hyperbilirubinemia
Background: Hyperbilirubinemia is a common problem in full-term newborns. Since the 1950s, phototherapy has been the choice of treatment for lowering bilirubin concentration in neo...
Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
Comparison of Intermittent vs. Continuous Phototherapy in the treatment of Non-Haemolytic Neonatal Hyperbilirubinemia
Introduction: Phototherapy is used in the treatment of hyperbilirubinemia in initial life-span of neonates. Our objective was the comparison of continuous vs intermittent photother...
Hypocalcaemia- The detrimental effect of phototherapy.
Hypocalcaemia- The detrimental effect of phototherapy.
Background: Jaundice is the single most common abnormal physical finding in the first week of life. Jaundice is observed during the 1st week of life in approximately 60% of term in...
Phototherapy-Induced Hypocalcemia in Icteric Term Neonates
Phototherapy-Induced Hypocalcemia in Icteric Term Neonates
Neonatal jaundice requiring phototherapy is a common condition, but phototherapy has been associated with potential side effects, including hypocalcemia. Understanding the frequenc...
Effects of Phototherapy on Platelet Counts in Low-Birthweight Infants and on Platelet Production and Life Span in Rabbits
Effects of Phototherapy on Platelet Counts in Low-Birthweight Infants and on Platelet Production and Life Span in Rabbits
The effects of conventional phototherapy on platelets in vivo were studied in rabbits and in low-birthweight infants.
Rabbits were divided into three groups and indi...

